Insmed, Inc. (INSM)
174.10
+0.01
(+0.01%)
USD |
NASDAQ |
Dec 31, 16:00
174.10
0.00 (0.00%)
After-Hours: 20:00
Insmed Profit Margin (Quarterly): -260.0% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 20.10% |
| Biogen, Inc. | 19.00% |
| Pfizer Inc. | 21.32% |
| Nektar Therapeutics | -301.3% |
| CorMedix, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -193.2% |
| Return on Assets | -55.21% |
| Return on Invested Capital | -70.98% |
| Gross Profit Margin (Quarterly) | 78.29% |
| Operating Margin (Quarterly) | -183.6% |
| Return on Net Operating Assets | -250.6% |